Skip to main content
. 2020 May 28;3:16. doi: 10.3389/fdata.2020.00016

Figure 8.

Figure 8

Counterfactual simulation of (A) lower disease severity in SP513 (shift of UPDRS3 scores at baseline to mean observed in Parkinson's Progression Markers Initiative (PPMI) at baseline), (B) shift of age 20 years up and down, and (C) treatment effect of ropinirole in PPMI.